Views: 0 Author: Kevin Fang Publish Time: 2026-09-01 Origin: Chensheng Medical
How to Conduct a Remote Factory Audit of a Chinese Medical Silicone Manufacturer (2026 Checklist)
TL;DR —
Remote factory audits have become the primary method for qualifying Chinese medical silicone tubing and catheter suppliers. A proper remote audit must verify ISO 13485 quality systems, cleanroom control (ISO 7 or better), full material traceability, and USP Class VI / ISO 10993 compliance. Jinan Chensheng Medical Technology operates a 8,000 m² facility with 80+ patents, ISO 13485 certification, and over 40 years of medical silicone production experience. Standard MOQ for custom medical silicone tubing starts at 5,000 meters with 12–18 working days lead time for first orders. This guide provides a structured audit framework with specific document requirements and evaluation criteria used by international medical device and pharmaceutical companies.
Key Takeaways
Remote audits can effectively qualify suppliers when structured around ISO 13485 Clause 7.4 and 8.4 requirements.
Infant-grade or food-grade silicone does not equal medical-grade; only materials tested to USP Class VI and ISO 10993 are acceptable for medical devices.
Cleanroom classification and environmental monitoring records are more critical than factory size for medical silicone extrusion.
Material traceability from raw silicone compound to finished tubing must be demonstrated in real time during the audit.
Typical MOQ for custom medical silicone tubing ranges from 3,000–10,000 meters depending on diameter and wall thickness.
Lead time from approved drawing to first production batch is usually 12–18 working days for companies with in-house tooling capability.
Medical silicone tubing used in infusion, respiratory, and drainage applications must comply with multiple overlapping standards. ISO 13485:2016 requires suppliers to maintain documented processes for supplier evaluation and monitoring. FDA 21 CFR 820.50 further mandates that device manufacturers verify the capability of critical component suppliers. USP <88> Class VI and ISO 10993-5/-10/-11 tests are the minimum biocompatibility requirements for fluid-contact medical silicone. During remote audits, auditors should request the most recent test reports issued by accredited laboratories such as SGS, TÜV, or Intertek, with test dates within the last 36 months.
Our medical silicone tubing page shows current compliance documentation available for download.
Medical silicone extrusion and assembly areas must operate under controlled environments. ISO 14644-1 Class 7 (ISO 7) cleanrooms are the minimum standard for non-sterile medical silicone components that will undergo later sterilization. Auditors should verify real-time differential pressure readings (minimum 10 Pa between clean and uncontrolled areas), temperature (18–24°C), and relative humidity (30–60%). Environmental monitoring data for viable and non-viable particles should be available for the previous 12 months.
Request the following documents at least 5 working days before the scheduled remote audit:
Current ISO 13485:2016 certificate with valid scope covering silicone extrusion and molding
USP Class VI and ISO 10993-5/-10 test reports for the specific silicone formulation
Cleanroom validation report and recent monitoring records
FDA registration number and listing for medical devices (if applicable)
Change control and deviation management procedures
During the live video tour, auditors should systematically inspect the following zones in sequence: raw material incoming inspection, silicone compounding area, extrusion workshop, post-cure ovens, cleanroom assembly, and final inspection laboratory. Particular attention should be paid to batch coding systems that link raw material lot numbers to finished tubing batch numbers.
Our production capability page provides detailed equipment specifications for medical silicone extrusion lines.
A typical remote-audit-qualified OEM/ODM project follows this timeline:
Requirement confirmation and DFM review: 3–5 working days
Material selection and sample production: 7–10 working days
Sample approval and first article inspection: 5–7 working days
Tooling modification (if needed) and process validation: 10–15 working days
Mass production start after batch release: 12–18 working days for first shipment
One common failure observed in remote audits is incomplete change control when raw material suppliers are changed. In one documented case, a supplier switched silicone base polymer without updating the formulation locked protocol, resulting in elevated extractables levels that failed pharmaceutical customer specifications. Proper suppliers maintain a formal “formulation lock” agreement with customers that prohibits any raw material change without prior written approval and re-validation.
Category | MOQ | Lead Time (First Order) | Unit Price Range (USD) |
Standard medical silicone tubing | 5,000 meters | 12–15 working days | 0.85–2.10 per meter |
Custom catheter / multi-lumen tubing | 3,000–8,000 meters | 15–22 working days | 1.80–6.50 per meter |
Respiratory circuit tubing | 10,000 meters | 18–25 working days | 1.20–3.80 per meter |
Confirm the exact scope stated on the current ISO 13485 certificate.
Request USP Class VI test reports for the specific silicone compound used in your product.
Verify cleanroom classification certificates and latest environmental monitoring data.
Ask for batch traceability records showing raw material lot to finished product linkage.
Confirm whether the supplier maintains a formal formulation lock agreement.
Request recent customer audit reports (anonymized) from medical device companies.
Verify the number of medical silicone extrusion lines and current capacity utilization.
Ask for the laboratory accreditation certificates of the testing house that issued biocompatibility reports.
Confirm the procedure for notifying customers of any raw material or process changes.
Request typical first-article inspection reports and acceptance criteria used for new projects.
Mistake 1: Accepting “medical grade” claims without reviewing actual USP Class VI and ISO 10993 reports for the specific formulation.
Correct approach: Always request the test reports with formulation identification numbers.
Mistake 2: Focusing only on factory size instead of cleanroom classification and process validation records.
Correct approach: Prioritize ISO 7 cleanroom validation and environmental monitoring data over total floor area.
Mistake 3: Failing to verify material traceability during the remote tour.
Correct approach: Request real-time demonstration of batch coding from raw material warehouse to finished goods.
Mistake 4: Accepting lead time promises without confirming in-house tooling and compounding capability.
Correct approach: Ask to see the tooling workshop and silicone compounding equipment during the virtual tour.
Mistake 5: Not requesting a formulation lock agreement before placing the first order.
Correct approach: Include formulation lock clauses in the supply agreement at the qualification stage.
A structured remote factory audit significantly reduces qualification risk when sourcing medical silicone tubing and catheters from China. Focus on verifiable compliance documents, real-time process visibility, and long-term change control mechanisms rather than marketing claims.
Share your product drawings, target market, and required certifications with our team. We will confirm compliance status within 24 hours and provide a DFM feasibility assessment within 48 hours.
Medical Silicone Tubing Product Page: https://www.jngxj.cn/
Published Technical Guides: https://www.jngxj.cn/news.html
Respiratory Circuit Silicone Components Guide
Pharmaceutical Grade Silicone Tubing Specifications
Kevin Fang | 21 years in medical silicone manufacturing | Jinan Chensheng Medical Technology Co., Ltd. (8,000 m² facility, 150+ employees, 80+ core patents) | Supplier to Class III hospitals and international medical device OEMs | ISO 13485 certified since 2012
Email: sales@jngxj.cn | WhatsApp: +86-18560016197
The minimum required documents include a valid ISO 13485:2016 certificate with extrusion and molding scope, USP Class VI and ISO 10993 test reports for the specific silicone formulation, cleanroom validation report, and recent environmental monitoring records. These documents should be reviewed at least five working days prior to the audit.
No. ISO 13485 is a quality management system standard. Biocompatibility testing according to USP <88> Class VI and ISO 10993 must be performed separately on the actual silicone compound used in production.
For custom diameters between 1.0 mm and 12.0 mm, the standard MOQ ranges from 3,000 to 8,000 meters depending on wall thickness and required tolerances. Smaller MOQs may be accepted for high-value multi-lumen or reinforced tubing.
A complete remote audit, including document review, virtual factory tour, and report generation, typically requires 8–12 working days when all requested documents are provided on time.
ISO 14644-1 Class 7 (ISO 7) is the minimum accepted classification for extrusion and assembly areas. Some customers additionally require ISO 5 laminar flow zones for critical assembly steps.
No. Reputable suppliers maintain a formal formulation lock agreement that prohibits any change to raw material grade, supplier, or processing parameters without prior written customer approval and re-validation.
After sample approval and process validation, the first mass production batch is typically completed within 12–18 working days for standard single-lumen medical silicone tubing.
Request that the supplier display live differential pressure, temperature, and humidity readings on camera and provide monitoring records from the previous 30 days with timestamps.
Contact us to schedule a remote audit →
Related Articles:
